Array BioPharma, Inc.

$ARRY - Nasdaq - Pharmaceuticals and Biotechnology
0 LAST
0 CHANGE $
0 CHANGE %
loader
ON 6
WATCHLISTS

COMMUNIQUÉ DETAILS

Up 0 0 Down
Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference

BOULDER, Colo., Jan. 3, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

Event:

Annual J.P. Morgan Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer, Array BioPharma

Date:

Tuesday, January 14, 2014

Time:

4:00 p.m. Pacific Time

Location:

Westin St. Francis Hotel, San Francisco

Webcast:

www.arraybiopharma.com

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520), for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and MEK162 (Novartis).  For more information on Array, please go to www.arraybiopharma.com

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

SOURCE Array BioPharma Inc.

SHARE THIS: Twitter StockTwits LinkedIn Google Plus SHORT URL: http://bdvt.co/cUgH

SIGN IN TO BOARDVOTE

FORGOT PASSWORD?